Scientific Advisory Board Member
Glenville Jones, Ph.D. is a Full Professor in the Departments of Biochemistry & Medicine, Queen’s University, Kingston, Ontario, Canada. Dr Jones has over 35 years of experience in teaching and research, mainly in academia but also industry, in Canada and the USA. His research interests focus on the biochemistry and pharmacology of vitamins A & D and the Liquid Chromatography-Mass Spectrometric (LC-MS) analysis of small molecules (lipidomics). After training with some of the world’s experts in the vitamin field in USA and UK, Dr Jones has been engaged in vitamin research that has been continuously funded by the Canadian Institutes for Health Research (CIHR) for the past three decades. With over 180 career publications, his work has defined the mechanisms by which vitamins A & D are broken down in the body by cytochrome P450-containing enzymes. In 1996, intellectual property from this work on cytochromes, CYP24 and CYP26 helped to spawn the founding of a company, Cytochroma Inc (Markham, Ontario, Canada) to commercialize some of these ideas and apply them to clinically-relevant problems such as chronic kidney disease, psoriasis, osteoporosis & certain cancers. He continues to serve on the Scientific Advisory Board of Cytochroma Inc.
Dr Jones obtained his BSc and PhD degrees from the University of Liverpool and he has held appointments at the Hospital for Sick Children in Toronto and the Departments of Biochemistry, Pediatrics & Graduate Studies at the University of Toronto, where he designed & applied clinical assays for vitamin D metabolites in patients with diseases of calcium metabolism. He has remained on the leading edge of analytical development in LC & MS fields. For the past 25 years he has been a professor of biochemistry at Queen’s University in Kingston and worked with many of the pharmaceutical players in the vitamin D & calcium fields including companies in Denmark, USA, Japan & Germany. Dr Jones has served on multiple CIHR & NIH-NCI grant panels, served on the editorial boards of J Bone Min Res and Dermato-Endocrinology; has reviewed for the Canadian, US, Israeli, S African, Austrian and Australian granting agencies; while also serving as a delegate that set global WHO/FAO dietary vitamin and mineral guidelines in 1998. Most recently (2009-2010), he has been involved in the US/Canada sponsored NAS/IOM committee setting nutritional guidelines for vitamin D and calcium.